Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma (original) (raw)
Figure 4
Relationship between serum miR-21 levels and the HAI score (A)
; (B), ROC curve analysis of serum miR-21 concentration for discriminating patients with minimal (HAIA+B+C≤3) vs. moderate to severe necroinflammatory activity (HAIA+B+C>3) using dCT of miR-21; (C), relationship between serum miR-21 and fibrosis index in patients with CHC.